» Articles » PMID: 39331367

Association of Dementia with Impaired Kidney Function and Plasma Biomarkers: A Population-based Study

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2024 Sep 27
PMID 39331367
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Emerging evidence has linked impaired kidney function with dementia in older adults, but the neuropathological pathways underlying their association remain poorly understood. We sought to examine the relationships of kidney function with dementia and plasma biomarkers in a Chinese rural population.

Methods: This population-based study used data from the baseline examination of the Multimodal Interventions to Delay Dementia and Disability in rural China (MIND-China) cohort (March-September 2018; n = 5715). Kidney function was assessed using estimated glomerular filtration rate (eGFR) based on serum creatinine level. Dementia, Alzheimer's disease (AD) and vascular dementia (VaD) were diagnosed according to the international criteria. Plasma biomarkers were measured using the SIMOA platform in a subsample (n = 1446). Data were analyzed using logistic, general linear, and mediation models.

Results: Of the 5715 participants, 306 were diagnosed with dementia, including 195 with AD and 100 with VaD. Impaired kidney function (eGFR <60 vs. ≥90 mL/min/1.73 m) was associated with multivariable-adjusted odds ratios of 2.24 (95% confidence interval [CI] 1.44-3.46) for all-cause dementia, 1.85 (1.07-3.18) for AD, and 2.49 (1.16-5.22) for VaD. In the biomarker subsample, impaired kidney function was significantly associated with higher plasma amyloid-β (Aβ)40 (β-coefficient = 54.36, 95% CI 43.34-65.39), Aβ42 (β-coefficient = 3.14, 95% CI 2.42-3.86), neurofilament light chain (β-coefficient = 10.62, 95% CI 5.62-15.62), and total tau (β-coefficient = 0.68, 95% CI 0.44-0.91), and a lower Aβ42/Aβ40 ratio (β-coefficient = -4.11, 95% CI -8.08 to -0.14). The mediation analysis showed that plasma total tau significantly mediated 21.76% of the association between impaired kidney function and AD (p < 0.05).

Conclusion: Impaired kidney function is associated with dementia and plasma biomarkers among rural-dwelling older Chinese adults, and the association with AD is partly mediated by plasma biomarkers for neurodegeneration.

Citing Articles

Association of dementia with impaired kidney function and plasma biomarkers: A population-based study.

Wang N, Ma Y, Liang X, Fa W, Tian X, Liu C Eur J Neurol. 2024; 31(12):e16488.

PMID: 39331367 PMC: 11555029. DOI: 10.1111/ene.16488.

References
1.
Alawode D, Heslegrave A, Ashton N, Karikari T, Simren J, Montoliu-Gaya L . Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. J Intern Med. 2021; 290(3):583-601. PMC: 8416781. DOI: 10.1111/joim.13332. View

2.
Cong L, Ren Y, Wang Y, Hou T, Dong Y, Han X . Mild cognitive impairment among rural-dwelling older adults in China: A community-based study. Alzheimers Dement. 2022; 19(1):56-66. PMC: 10078715. DOI: 10.1002/alz.12629. View

3.
Gonzalez-Ortiz F, Turton M, Kac P, Smirnov D, Premi E, Ghidoni R . Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration. Brain. 2022; 146(3):1152-1165. PMC: 9976981. DOI: 10.1093/brain/awac407. View

4.
Stocker H, Beyer L, Trares K, Perna L, Rujescu D, Holleczek B . Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers. JAMA Netw Open. 2023; 6(1):e2252387. PMC: 10408272. DOI: 10.1001/jamanetworkopen.2022.52387. View

5.
Soveri I, Berg U, Bjork J, Elinder C, Grubb A, Mejare I . Measuring GFR: a systematic review. Am J Kidney Dis. 2014; 64(3):411-24. DOI: 10.1053/j.ajkd.2014.04.010. View